The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study
Objectives. Medication-related osteonecrosis of the jaw (MRONJ) is defined as exposed bone in the maxillofacial region persisting for more than eight weeks in patients who are or were treated with antiresorptive or antiangiogenic agents and had no radiation therapy to the craniofacial region or obvi...
Guardado en:
Autores principales: | Jiri Zelinka, Jiri Blahak, Vojtech Perina, Rita Pacasova, Jana Treglerova, Oliver Bulik |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Palacký University Olomouc, Faculty of Medicine and Dentistry
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f4f1889e55b458b812c167c3077711a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin
por: Öznur Özalp, et al.
Publicado: (2021) -
Platelet-rich fibrin: Basics of biological actions and protocol modifications
por: Pavlovic Voja, et al.
Publicado: (2021) -
Platelet-rich plasma and platelet-rich fibrin as a regenerative tool
por: Athiban Inbarajan, et al.
Publicado: (2021) -
Association between platelet-rich fibrin and collagen matrix for root coverage: Case Series.
por: Tinajero-Aroni,Mauricio Andres, et al.
Publicado: (2021) -
Method for Management of Perianal Fistula with New Device: Progressive Curettage of the Tract and Sealing with Platelet-Rich Fibrin
por: Francisco Javier Perez Lara, et al.
Publicado: (2016)